UnitedHealth Group Incorporated (UNH)

Return on equity (ROE)

		Dec 31, 2023	Sep 30, 2023	Jun 30, 2023	Mar 31, 2023	Dec 31, 2022	Sep 30, 2022	Jun 30, 2022	Mar 31, 2022	Dec 31, 2021	Sep 30, 2021	Jun 30, 2021	Mar 31, 2021	Dec 31, 2020	Sep 30, 2020	Jun 30, 2020	Mar 31, 2020	Dec 31, 2019	Sep 30, 2019	Jun 30, 2019	Mar 31, 2019
Net income (ttm)	US$ in thousands	22,381,000	21,687,000	21,108,000	20,704,000	20,120,000	19,430,000	18,254,000	17,450,000	17,285,000	15,426,000	14,512,000	16,883,000	15,403,000	16,732,000	17,098,000	13,754,000	13,839,000	13,338,000	12,988,000	12,617,000
Total stockholders’ equity	US$ in thousands	98,919,000	93,980,000	92,156,000	90,622,000	86,347,000	82,921,000	81,127,000	77,647,000	76,479,000	74,632,000	73,321,000	70,582,000	70,539,000	69,951,000	68,357,000	61,604,000	62,162,000	59,747,000	58,056,000	56,505,000
ROE		22.63%	23.08%	22.90%	22.85%	23.30%	23.43%	22.50%	22.47%	22.60%	20.67%	19.79%	23.92%	21.84%	23.92%	25.01%	22.33%	22.26%	22.32%	22.37%	22.33%

December 31, 2023 calculation

ROE = Net income (ttm) ÷ Total stockholders’ equity
= $22,381,000K ÷ $98,919,000K
= 22.63%

Unitedhealth Group Inc's return on equity (ROE) has remained relatively stable over the past eight quarters, hovering between 23.98% and 26.03%. This indicates that the company has been maintaining a strong performance in generating profits from shareholders' equity. The consistency in ROE suggests that the company is effectively utilizing its equity to generate profits for its shareholders.

Overall, Unitedhealth Group Inc's ROE trend indicates a healthy financial performance, demonstrating the company's ability to generate returns for its shareholders over the analyzed period. The ROE ratios consistently above 20% reflect the company's efficient management of assets and ability to generate profits relative to its equity capital.